 | This article includes a list of general references, but it lacks sufficient corresponding inline citations. (April 2024) |
Jay Keasling | |
|---|---|
 Dr. Jay D. Keasling speaking at PopTech Energy Salon 2011 in New York City | |
| Alma mater | University of Nebraska-Lincoln University of Michigan |
| Known for | metabolic engineering |
| Awards | Bill & Melinda Gates Foundation grant, Heinz Award in Technology, the Economy & Employment |
| Scientific career | |
| Institutions | University of California, Berkeley, University of Nebraska-Lincoln, University of Michigan |
| Thesis | Dynamics and control of bacterial plasmid replication (1991) |
| Doctoral advisor | Bernhard Palsson[1] |
| Doctoral students | Kristala Jones Prather |
| Other notable students | Michelle C. Chang |
| Website | keaslinglab |
Jay D. Keasling is a professor[ambiguous] of chemical engineering and bioengineering at the University of California, Berkeley.[2] He is also associate laboratory director for biosciences at the Lawrence Berkeley National Laboratory and chief executive officer of the Joint BioEnergy Institute.[3] He is considered one of the foremost authorities in synthetic biology, especially in the field of metabolic engineering.
Keasling was elected a member of the National Academy of Engineering in 2010 for developing synthetic biology tools to engineer the antimalarial drug artemisinin.
- ^ Palsson laboratory alumni. Gcrg.ucsd.edu. Retrieved 22 May 2012. [dead link]
- Palsson, B. O.; Keasling, J. D.; Emerson, S. G. (1990). "The regulatory mechanisms of human immunodeficiency virus replication predict multiple expression rates". Proceedings of the National Academy of Sciences of the United States of America. 87 (2): 772–776. Bibcode:1990PNAS...87..772P. doi:10.1073/pnas.87.2.772. PMC 53348. PMID 2405389. - ^ Jay D. Keasling faculty page, UC Berkeley. Retrieved 22 May 2012.
- The Keasling Lab web site - ^ "About", Joint BioEnergy Institute